Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

ABBOTT LABORATORIES

(ABT)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

ABBOTT LABORATORIES : Change in Directors or Principal Officers, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits (form 8-K)

09/01/2021 | 07:13am EDT

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

On August 30, 2021, Patricia P. Gonzalez was named to the Abbott Laboratories' ("Abbott") Board of Directors.

Item 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year.

On August 30, 2021, Abbott's Board of Directors amended the first sentence of Article III, Section 2 of Abbott's by-laws to provide that Abbott's Board of Directors shall consist of fourteen persons, effective as of August 30, 2021. Abbott's by-laws previously provided that the Board of Directors consisted of thirteen persons.


Item 9.01      Financial Statements and Exhibits.



  Exhibit No. Exhibit




   3.1     By-Laws of Abbott Laboratories, as amended and restated effective
         August 30, 2021.



104 Cover Page Interactive Data File (the cover page XBRL tags are embedded in

the Inline XBRL document).

© Edgar Online, source Glimpses

All news about ABBOTT LABORATORIES
10/21GLOBAL MARKETS LIVE : Tesla, Unilever, Paypal, Elliott, Novartis...
10/21ABBOTT LABORATORIES : UBS Adjusts Price Target on Abbott Laboratories to $138 From $131, M..
MT
10/21ABBOTT LABORATORIES : JPMorgan Adjusts Price Target for Abbott Laboratories to $140 From $..
MT
10/21ABBOTT LABORATORIES : Morgan Stanley Adjusts Abbott Laboratories' Price Target to $146 fro..
MT
10/21ABBOTT LABORATORIES : Raymond James Adjusts Price Target on Abbott Laboratories to $134 fr..
MT
10/21ABBOTT LABORATORIES : SVB Leerink Adjusts Abbott Laboratories' Price Target to $140 from $..
MT
10/21ABBOTT LABORATORIES : Reports third-quarter 2021 results, achieves strong double-digit ear..
AQ
10/20Dow Jones Industrial Average : Strong earnings reports lift Wall Street
RE
10/20Brinker, Baker Hughes fall; Anthem, Abbott Laboratories rise
AQ
10/20Health Care Stocks Rally for Second Consecutive Day
MT
More news
Analyst Recommendations on ABBOTT LABORATORIES
More recommendations
Financials (USD)
Sales 2021 41 861 M - -
Net income 2021 6 575 M - -
Net Debt 2021 8 432 M - -
P/E ratio 2021 34,2x
Yield 2021 1,34%
Capitalization 224 B 224 B -
EV / Sales 2021 5,56x
EV / Sales 2022 5,72x
Nbr of Employees 109 000
Free-Float 88,8%
Chart ABBOTT LABORATORIES
Duration : Period :
Abbott Laboratories Technical Analysis Chart | ABT | US0028241000 | MarketScreener
Technical analysis trends ABBOTT LABORATORIES
Short TermMid-TermLong Term
TrendsNeutralNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 25
Last Close Price 126,58 $
Average target price 135,61 $
Spread / Average Target 7,14%
EPS Revisions
Managers and Directors
Robert B. Ford President, CEO, Chief Operating Officer & Director
Robert Emmett Funck Chief Financial Officer & Executive VP-Finance
Miles D. White Executive Chairman
Sabina Ewing Chief Investment Officer, VP-Business & Technology
Roxanne Schuh Austin Independent Director
Sector and Competitors
1st jan.Capi. (M$)
ABBOTT LABORATORIES15.61%224 403
MEDTRONIC PLC5.48%166 288
BECTON, DICKINSON AND COMPANY-1.52%70 767
HOYA CORPORATION20.25%55 682
DEXCOM, INC.53.72%54 986
SARTORIUS STEDIM BIOTECH65.87%51 705